WHO ICTRP trial
Expanded Treatment Efficacy and Safety Study of Transcatheter Arterial…
JPRN-UMIN000000975 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000000975 |
|---|---|
| Public title | Expanded Treatment Efficacy and Safety Study of Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Epirubicin/ Doxorubicin-Lipiodol Emulsion and Gelatin Particles: Korea-Japan Cooperative Study (JIVROSG-0604) |
| Scientific title | Expanded Treatment Efficacy and Safety Study of Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Epirubicin/ Doxorubicin-Lipiodol Emulsion and Gelatin Particles: Korea-Japan Cooperative Study (JIVROSG-0604) - Expanded Treatment Efficacy and Safety Study of TACE… |
| Primary sponsor | Japan Interventional Radiology in Oncology Study Group (JIVROSG) |
| Secondary sponsors | Korea Interventional Radiology in Oncology Study Group (KIVROSG) |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan,Asia(except Japan) |
| Conditions | hepatocellular carcinoma |
| Interventions | Patients with unresectable HCC undergo TACE using an emulsion of epirubicin HCl or doxorubicin HCl and Lipiodol, followed by injection of gelatin sponge particles. The same treatment is repeated if the tumor demonstrates progression. |
| Registration date | Aug 1, 2008 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: